Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain, Rash, Rash erythematous, Tenderness
Clinical narrative: intense red rash; The intense red rash and extreme sensitivity lasted 3 months. It was on the same side as the injections; Serious patch of rash, 4x4 inch on left back shoulder around shoulder blade, much pain; Serious patch of rash; felt a little lightheaded, not dizzy, not one hundred percent; slight tenderness in arm but was able to sleep on it; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt a little lightheaded, not dizzy, not one hundred percent), TENDERNESS (slight tenderness in arm but was able to sleep on it), RASH ERYTHEMATOUS (intense red rash), PAIN (Serious patch of rash, 4x4 inch on left back shoulder around shoulder blade, much pain) and RASH (Serious patch of rash) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Dust allergy, Grass allergy, Hyperlipidemia, Hypertension and Basal cell carcinoma. Concomitant products included LOSARTAN, AMLODIPINE and BISOPROLOL FUMARATE (ZEBETA) for Hypertension, ROSUVASTATIN and BISOPROLOL FUMARATE for an unknown indication.   On 16-Jan-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 16-Jan-2021, the patient experienced DIZZINESS (felt a little lightheaded, not dizzy, not one hundred percent) and TENDERNESS (slight tenderness in arm but was able to sleep on it). On 06-Mar-2021, the patient experienced PAIN (Serious patch of rash, 4x4 inch on left back shoulder around shoulder blade, much pain) and RASH (Serious patch of rash). On an unknown date, the patient experienced RASH ERYTHEMATOUS (intense red rash) and VACCINATION SITE RASH (The intense red rash and extreme sensitivity lasted 3 months. It was on the same side as the injections). The patient was treated with TRIAMCINOLONE ACETONIDE for Rash, at a dose of 1 percent. On 17-Jan-2021, DIZZINESS (felt a little lightheaded, not dizzy, not one hundred percent) and TENDERNESS (slight tenderness in arm but was able to sleep on it) had resolved. On 10-Apr-2021, PAIN (Serious patch of rash, 4x4 inch on left back shoulder around shoulder blade, much pain) and RASH (Serious patch of rash) had resolved. At the time of the report, RASH ERYTHEMATOUS (intense red rash) and VACCINATION SITE RASH (The intense red rash and extreme sensitivity lasted 3 months. It was on the same side as the injections) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Crestor generic(rosuvastatin).   This case was linked to US-MODERNATX, INC.-MOD-2021-069767, MOD21-071085, US-MODERNATX, INC.-MOD-2021-070005 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Patient demographics( Height, Weight, Race, Ethnicity), Allergies, Medical history and concomitant medications and events(Rash and Pain) added. On 16-Jul-2021: Follow up received on 16 JUL 2021: No new information; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-069767: MOD21-071085: US-MODERNATX, INC.-MOD-2021-070005: Dose 2